Comparative efficacy and safety of pharmacological interventions for postmenopausal osteoporosis: a network meta-analysis
Characterized as a common chronic metabolic bone disease, postmenopausal osteoporosis (PMOP) leads to fractures, functional impairment, and a higher risk of death in middle-aged and elderly women. Although various pharmacological interventions are available, their comparative efficacy and safety profiles remain uncerta...